Early research (Phase 1)Ended earlyNCT01329744What this trial is testingEffects of IGF-I in HIV Metabolic DiseaseWho this might be right forHIV Lipodystrophy University of Texas Southwestern Medical Center 16
Large-scale testing (Phase 3)Study completedNCT00383734What this trial is testingSafety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILEWho this might be right forHIV-Associated Lipodystrophy Syndrome French National Agency for Research on AIDS and Viral Hepatitis 148
Large-scale testing (Phase 3)Study completedNCT01077765What this trial is testingPolyacrylamide Hydrogel Injection in HIV-related LipoatrophyWho this might be right forHIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection Assistance Publique - Hôpitaux de Paris 100
Post-approval studies (Phase 4)Ended earlyNCT03226821What this trial is testingBody Composition and Adipose Tissue in HIVWho this might be right forHIV Lipodystrophy SyndromeGrowth Hormone DeficiencyBody Composition Columbia University 6
Post-approval studies (Phase 4)Study completedNCT00646984What this trial is testingStrategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With LipodystrophyWho this might be right forHIV-Associated Lipodystrophy Syndrome Hospital Clinic of Barcelona 147
Early research (Phase 1)Study completedNCT02342223What this trial is testingVoluma Filler Agent For The Treatment of HIV-associated Facial LipoatrophyWho this might be right forHIV Facial Lipoatrophy Jared Jagdeo, MD, MS 20
Testing effectiveness (Phase 2)Study completedNCT00461552What this trial is testingTherapeutic Approaches to HAART-Induced LipodystrophyWho this might be right forHIV InfectionsLipodystrophy University of Texas Southwestern Medical Center 23
Not applicableStudy completedNCT02530827What this trial is testingEnergy Expenditure of People Living With HIV/AIDSWho this might be right forHIV/AIDSHIV Lipodystrophy Syndrome University of Sao Paulo General Hospital 45
Post-approval studies (Phase 4)Study completedNCT04340388What this trial is testingContribution of Dolutegravir to Obesity and Cardiovascular DiseaseWho this might be right forHIV-1-infectionAntiviral Drug Adverse ReactionVascular Diseases+5 more Augusta University 10
Not applicableStudy completedNCT05383456What this trial is testingThe Visceral Adiposity Measurement and Observation StudyWho this might be right forHIVHIV-InfectionsHIV-1-infection+16 more Theratechnologies 196
Post-approval studies (Phase 4)Study completedNCT00135356What this trial is testingStudy of Reyataz in HIV-infected Patients With Lipodystrophy SyndromeWho this might be right forHIV-Associated Lipodystrophy Syndrome Bristol-Myers Squibb 219
Not applicableStudy completedNCT01359917What this trial is testingPsychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment OutcomeWho this might be right forHIV-Associated Lipodystrophy Syndrome NHS Lothian 50
Large-scale testing (Phase 3)Study completedNCT00123253What this trial is testingTH9507 in Patients With HIV-Associated LipodystrophyWho this might be right forHIV InfectionsLipodystrophy Theratechnologies 412
Post-approval studies (Phase 4)Study completedNCT00139178What this trial is testingSwitching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.Who this might be right forHIV Associated Lipodystrophy Syndrome.HIVHypercholesterolemia+1 more Danish HIV Research Group 100
Large-scale testing (Phase 3)Study completedNCT00608023What this trial is testingTH9507 Extension Study in Patients With HIV-Associated LipodystrophyWho this might be right forLipodystrophyHIV Infections Theratechnologies 263